Tenax Therapeutics Statistics

Total Valuation

TENX has a market cap or net worth of $206.69 million. The enterprise value is $111.84 million.

Market Cap	206.69M
Enterprise Value	111.84M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TENX has 35.85 million shares outstanding. The number of shares has increased by 6,046.87% in one year.

Current Share Class	3.97M
Shares Outstanding	35.85M
Shares Change (YoY)	+6,046.87%
Shares Change (QoQ)	+66.79%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	10.86%
Float	3.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.21
P/TBV Ratio	2.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.60

Current Ratio	20.60
Quick Ratio	20.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-847.57

Financial Efficiency

Return on equity (ROE) is -35.17% and return on invested capital (ROIC) is -24.22%.

Return on Equity (ROE)	-35.17%
Return on Assets (ROA)	-22.49%
Return on Invested Capital (ROIC)	-24.22%
Return on Capital Employed (ROCE)	-21.19%
Revenue Per Employee	n/a
Profits Per Employee	-$2.93M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.00% in the last 52 weeks. The beta is 1.91, so TENX's price volatility has been higher than the market average.

Beta (5Y)	1.91
52-Week Price Change	+50.00%
50-Day Moving Average	5.97
200-Day Moving Average	5.11
Relative Strength Index (RSI)	50.04
Average Volume (20 Days)	14,911

Short Selling Information

The latest short interest is 336,098, so 0.94% of the outstanding shares have been sold short.

Short Interest	336,098
Short Previous Month	364,345
Short % of Shares Out	0.94%
Short % of Float	8.58%
Short Ratio (days to cover)	15.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.49M
Pretax Income	-10.10M
Net Income	-17.60M
EBITDA	-19.49M
EBIT	-19.49M
Earnings Per Share (EPS)	-$1.15

Full Income Statement

Balance Sheet

The company has $94.85 million in cash and n/a in debt, giving a net cash position of $94.85 million or $2.65 per share.

Cash & Cash Equivalents	94.85M
Total Debt	n/a
Net Cash	94.85M
Net Cash Per Share	$2.65
Equity (Book Value)	91.99M
Book Value Per Share	2.61
Working Capital	91.99M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-14.81M
Capital Expenditures	n/a
Free Cash Flow	-14.81M
FCF Per Share	-$0.41

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TENX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6,046.87%
Shareholder Yield	n/a
Earnings Yield	-8.52%
FCF Yield	-7.17%

Analyst Forecast

The average price target for TENX is $16.00, which is 173.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	173.50%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 3, 2024. It was a reverse split with a ratio of 0.0125:1.

Last Split Date	Jan 3, 2024
Split Type	Reverse
Split Ratio	0.0125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2